Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 5/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.62 |
| ▸ | SCN1A | P35498 | 3/20 | 0.62 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.62 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.55 |
| ▸ | HRH1 | P35367 | 4/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.55 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.55 |
| ▸ | HTR2A | P28223 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | THPO | P40225 | 2/20 | 0.55 |
| ▸ | DRD1 | P21728 | 2/20 | 0.55 |
| ▸ | HTR2C | P28335 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19381942 | 0.79 | CHRM2 (0.66) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| SCHEMBL343645 | 0.77 | HRH1 (0.41) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| Pheniramine SCHEMBL4796 | 0.77 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| Pheniramine SCHEMBL30182646 | 0.77 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| Pheniramine SCHEMBL126153 | 0.77 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| SCHEMBL19368168 | 0.77 | CHRM2 (0.62) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| Pheniramine SCHEMBL48720 | 0.77 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| Pheniramine SCHEMBL365145 | 0.75 | CHRM2 (0.97) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| Pheniramine SCHEMBL18240052 | 0.75 | CHRM2 (0.97) | CHRM2SLC6A2SLC6A4SCN1ASCN2A | |
| SCHEMBL18157956 | 0.73 | CHRM2 (0.47) | CHRM2SLC6A2SLC6A4SCN1ASCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338600-B2 | Copper-oxygen adduct complexes, and methods of making and use | JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) | 2012-12-25 | — | — | US | claimed |
| EP-2215096-B1 | COPPER-OXYGEN ADDUCT COMPLEXES | UNIV GIESSEN JUSTUS LIEBIG (DE) | 2012-09-19 | — | — | EP | claimed |
| US-20120016127-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) | 2012-01-19 | — | — | US | claimed |
| EP-2215096-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | Justus-Liebig-Universität Gießen (DE) | 2010-08-11 | — | — | EP | claimed |
| WO-2009052809-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) | 2009-04-30 | — | — | WO | claimed |
| US-8338600-B2 | Copper-oxygen adduct complexes, and methods of making and use | JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) | 2012-12-25 | — | — | US | disclosed |
| EP-2215096-B1 | COPPER-OXYGEN ADDUCT COMPLEXES | UNIV GIESSEN JUSTUS LIEBIG (DE) | 2012-09-19 | — | — | EP | disclosed |
| US-20120016127-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) | 2012-01-19 | — | — | US | disclosed |
| EP-2215096-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | Justus-Liebig-Universität Gießen (DE) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009052809-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016127-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | AOC2, AOC3, AOC1 | CHRM2 2513/4885SLC6A2 1140/4885SLC6A4 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.